Pharmacokinetic profile and endocrine effects of posatirelin treatment in healthy elderly subjects

Journal of Clinical Pharmacology

Volumn 36, Issue 9, 1996, Pages 823-831

  Reboldi, Gianpaolo ^a   Parnetti, Lucilla ^a   Santeusanio, Fausto ^a   Ambrosoli, Laura ^b   Palumbo, Barbara ^a   Cherubini, Antonio ^a   Girardello, Roberto ^b   Poli, Aldo ^b   Lowenthal, David T ^c   Senin, Umberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Poli Industria Chimica SpA   (Italy)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LIOTHYRONINE; POSATIRELIN; PROLACTIN; THYROTROPIN; THYROXINE;

AGED; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERANCE; ENDOCRINE FUNCTION; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; THYROID FUNCTION;

EID: 10144235822     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04256.x     Document Type: Article

References (25)

1. Drago F, Grassi M, Valerio C, Coppi G, Lauria N, Nicotra GC, Raffaele R: Behavioral changes induced by the thyrotropin-releasing hormone analogue RGH-2202. Peptides 1991;12:1309-1313.
2. Coppi G, Falcone A: The thyrotropin releasing hormone analogue, RGH-2002, reverses experimental haemorrhagic shock in rats. Eur J Pharmacol 1990;182:185-188.
3. Sims NR, Bowen DM: Changes in choline acetyltransferase and in acetylcholine synthesis. In, Reisberg B (ed.): Alzheimer's Disease. New York: Free Press, 1983;88-92.
4. Oka M, Ochi Y, Furukawa K, Ito T, Miura Y, Karasawa T, Kadokawa T: L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous system functions. Arzneimittelforschung 1989;39:297-303.
5. Casabona G, Bruno V, Catania MV, Sortino MA, Nicoletti F, Scapagnini U, Canonico PL: Thyrotropin releasing hormone and its analog, RGH-2002, accelerate maturation of cerebellar neurons in vitro. Dev Brain Res 1992;69:179-183.
6. Askanas V, Engel WK, Eagleson K, Micaglio G: Influence of TRH and TRH analogues, RGH-2002 and DN-1417 on cultured ventral spinal cord neurons. Ann N Y Acad Sci 1989;553:325-336.
7. Shibata H: Phase I study of RGH-2202 (single-dose study). Tokyo, Japan: Dainippon Internal Report, 1987.
8. Costantini S, Del Buono R, Bellanova R, Nencioni A, Cucinotta D: Short term controlled clinical trial with posatirelin in elderly patients with dementia. In, Beregi E, Gergely IA, Rajczi K (eds.): Recent Advances in Aging Science. Bologna, Italy: Monduzzi, 1993;711-716.
9. Parnetti L, Ambrosoli L, Abate G, Azzini C, Balestreri R, Bartorelli L, et al: Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid. Acta Neurol Scand 1995;92:135-140.
10. Folstein MF, Folstein SE, McHugh PR: Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
12. Terauchi Y, Ishikawa S, Oida S, Negoro T, Kagemoto A, Sekine Y: Determination of L-6-keto-piperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a new analog of thyrotropin-releasing hormone, in plasma by radioimmunoassay. J Pharmacobiodyn 1988;11:459-464.
13. Hunter WH, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962;194:495-496.
14. Whitehead TP, Thorpe GHG, Carter TJN, Groucutt C, Krika LJ: Enhanced luminescence procedure for sensitive determination of peroxidase-labelled conjugates in immunoassay. Nature 1983;305:158-159.
15. Ekins R: Measurement of free hormones in blood. Endocr Rev 1990;11:5-46.
16. Gibaldi M, Perrier D: Pharmacokinetics. Second edition. New York: Marcel Dekker, 1982.
17. Ritschel WA: Handbook of Clinical Pharmacokinetics. Fourth edition. Hamilton, IL: Drug Intelligence Corporation, 1992.
18. Zar JH: Bioslatistical Analysis. Second edition. Englewood Cliffs, NJ: Prentice-Hall Inc., 1984.
19. Sokal RR, Rohlf FJ: Biometry: The Principle and Practice of Statistics in Biological Research. Third edition. New York: WH Freeman and Company, 1995.
20. Tumer N, Scarpace PJ, Lowenthal DT: Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol 1992;32:271-302.
21. Ruiz JC, Lowenthal DT: Geriatric pharmacology. In, Munson P (ed.): Clinical Pharmacology. New York: Chapman and Hall, 1995;1717-1726.
22. Maeda K, Yoshimoto Y, Yamadori A: Blunted TSH and unaltered PRL responses to TRH following repeated administration of TRH in neurologic patients: a replication of neuroendocrine features of major depression. Biol Psychiatry 1993;33:277-283.
23. Monzani F, Pucci E, Fierabracci P, Nebbiai G, Coli A, Caraccio N, et al: Long term intramuscular administration of thyrotropin-releasing hormone tartrate in patients with cerebrovascular disease: effects on the pituitary-thyroid axis. Horm Res 1991;35:146-150.
24. Chopra IJ: Nature, sources and relative biologic significance of circulating thyroid hormones. In, Braverman LE, Utiger RD (eds.): The Thyroid: A Fundamental and Clinical Text. Sixth edition. Philadelphia: JB Lippincott, 1991;126-143.
25. Franceschi M, Perego L, Ferini-Strambi L, Smirne S, Canal N: Neuroendocrinological function in Alzheimer's disease. Neuroendocrinology 1988;48:367-370.